Logo image of CCEP

COCA-COLA EUROPACIFIC PARTNE (CCEP) Stock Analyst Ratings

NASDAQ:CCEP - Nasdaq - GB00BDCPN049 - Common Stock - Currency: USD

78.55  -0.77 (-0.97%)

After market: 78.55 0 (0%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to CCEP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 86.44. This target is 10.04% above the current price.
CCEP was analyzed by 23 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about CCEP.
In the previous month the buy percentage consensus was at a similar level.
CCEP was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
CCEP Historical Analyst RatingsCCEP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 78.5576.8186.9786.4499.75 - -2.21% 10.72% 10.04% 26.99%
CCEP Current Analyst RatingCCEP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-01-17 Barclays Maintains Overweight -> Overweight
2024-12-12 UBS Maintains Buy -> Buy
2024-12-03 Bernstein Initiate Market Perform
2024-11-27 JP Morgan Downgrade Overweight -> Neutral
2024-11-07 Barclays Maintains Overweight -> Overweight
2024-11-06 Evercore ISI Group Maintains Outperform -> Outperform
2024-10-11 Barclays Maintains Overweight -> Overweight
2024-09-09 Deutsche Bank Maintains Buy -> Buy
2024-08-09 Barclays Maintains Overweight -> Overweight
2024-07-19 Barclays Maintains Overweight -> Overweight
2024-07-10 B of A Securities Maintains Buy -> Buy
2024-05-14 Barclays Maintains Overweight -> Overweight
2024-04-29 Barclays Maintains Overweight -> Overweight
2024-03-28 Deutsche Bank Maintains Buy -> Buy
2024-03-19 Argus Research Maintains Buy -> Buy
2024-02-27 Barclays Maintains Overweight -> Overweight
2024-02-26 UBS Maintains Buy -> Buy
2024-01-16 Barclays Maintains Overweight -> Overweight
2024-01-12 Exane BNP Paribas Upgrade Neutral -> Outperform
2023-12-05 Goldman Sachs Maintains Buy -> Buy
2023-12-04 Goldman Sachs Upgrade Neutral -> Buy
2023-11-29 JP Morgan Maintains Overweight -> Overweight
2023-10-12 Barclays Maintains Overweight -> Overweight
2023-10-09 Evercore ISI Group Maintains Outperform -> Outperform
2023-08-04 Barclays Maintains Overweight -> Overweight
2023-07-20 Barclays Maintains Overweight -> Overweight
2023-07-05 JP Morgan Maintains Overweight -> Overweight
2023-05-26 Argus Research Maintains Buy
2023-04-27 Barclays Maintains Overweight
2023-04-26 Societe Generale Upgrade Sell -> Hold